Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE)

Neurochemistry International

Volumn 59, Issue 1, 2011, Pages 28-38

  Musgrave, Travis ^a   Tenorio, Gustavo ^a   Rauw, Gail ^a   Baker, Glen B ^a   Kerr, Bradley J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

5 HT; Amino acids; Biogenic amines; d Serine; Experimental autoimmune encephalomyelitis; GABA; Glutamate; Multiple sclerosis; Neurotransmitters

Indexed keywords

AMINO ACID; BIOGENIC AMINE; SERINE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HYPOTHALAMUS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TISSUE LEVEL;

AMINO ACIDS; ANIMALS; BIOGENIC AMINES; CENTRAL NERVOUS SYSTEM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL;

ANIMALIA; MUS;

EID: 79960154155     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2011.03.020     Document Type: Article

References (52)

1. O. Andersen, B.B. Johansson, and L. Svennerholm Monoamine metabolites in successive samples of spinal fluid A comparison between healthy volunteers and patients with multiple sclerosis Acta Neurol. Scand. 63 1981 247 254 (Pubitemid 11136540)
2. V.P. Barkhatova, I.A. Zavalishin, L. Askarova, V. Shavratskii, and E.G. Demina Changes in neurotransmitters in multiple sclerosis Neurosci. Behav. Physiol. 28 1998 341 344 (Pubitemid 128695890)
3. A.G. Baxter The origin and application of experimental autoimmune encephalomyelitis Nat. Rev. Immunol. 7 2007 904 912 (Pubitemid 350006239)
4. Begolka, W.S.,Miller, S.D., 1998. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res. Immunol., 149, 771-781, discussion 843-774, 855-760.
5. J.L. Berard, K. Wolak, S. Fournier, and S. David Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice Glia 58 2010 434 445
6. R. Bhat, R. Axtell, A. Mitra, M. Miranda, C. Lock, R.W. Tsien, and L. Steinman Inhibitory role for GABA in autoimmune inflammation Proc. Natl. Acad. Sci. USA 107 2010 2580 2585
7. D. Centonze, L. Muzio, and S. Rossi Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis J. Neurosci. 29 2009 3442 3452
8. D. Centonze, L. Muzio, S. Rossi, R. Furlan, G. Bernardi, and G. Martino The link between inflammation, synaptic transmission and neurodegeneration in multiple sclerosis Cell Death Differ. 17 2010 1083 1091
9. A.M. Courtney, K. Treadaway, G. Remington, and E. Frohman Multiple sclerosis Med. Clin. North Am. 93 2009 451 476, ix-
10. D. Davidson, I.A. Pullar, C. Mawdsley, N. Kinloch, and C.M. Yates Monoamine metabolites in cerebrospinal fluid in multiple sclerosis J. Neurol. Neurosurg. Psychiatry 40 1977 741 745 (Pubitemid 8203114)
11. T.J. de Koning, K. Snell, M. Duran, R. Berger, B.T. Poll-The, and R. Surtees Lserine in disease and development Biochem. J. 371 2003 653 661
12. E.V. Demakova, V.P. Korobov, and L.M. Lemkina [Determination of gamma-aminobutyric acid concentration and activity of glutamate decarboxylase in blood serum of patients with multiple sclerosis] Klin Lab Diagn 2003 15 17
13. M. Froh, R.G. Thurman, and M.D. Wheeler Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes Am. J. Physiol. Gastrointest. Liver Physiol. 283 2002 G856 863
14. S.L. Grant, Y. Shulman, P. Tibbo, D.R. Hampson, and G.B. Baker Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 844 2006 278 282 (Pubitemid 44792012)
15. R. Gold, C. Linington, and H. Lassmann Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain 129 2006 1953 1971 (Pubitemid 44289062)
16. Z. Gottesfeld, D. Teitelbaum, C. Webb, and R. Arnon Changes in the GABA system in experimental allergic encephalomyelitis-induced paralysis J. Neurochem. 27 1976 695 699
17. H. Hardin-Pouzet, M. Krakowski, L. Bourbonniere, M. Didier-Bazes, E. Tran, and T. Owens Glutamate metabolism is down-regulated in astrocytes during experimental allergic encephalomyelitis Glia 20 1997 79 85 (Pubitemid 27207010)
18. H.H. Hofstetter, R. Mossner, K.P. Lesch, R.A. Linker, K.V. Toyka, and R. Gold Absence of reuptake of serotonin influences susceptibility to clinical autoimmune disease and neuroantigen-specific interferon-gamma production in mouse EAE Clin. Exp. Immunol. 142 2005 39 44 (Pubitemid 41361003)
19. C.G. Honegger, W. Krenger, and H. Langemann Changes in amino acid contents in the spinal cord and brainstem of rats with experimental autoimmune encephalomyelitis J. Neurochem. 53 1989 423 427 (Pubitemid 19186075)
20. A. Kalyvas, and S. David Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease Neuron 41 2004 323 335 (Pubitemid 38221038)
21. W. Krenger, C.G. Honegger, C. Feurer, and S. Cammisuli Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord J. Neurochem. 47 1986 1247 1254 (Pubitemid 16032489)
22. W. Krenger, A. Kabiersch, and C.G. Honegger Monoamines and related substances in brainstem and spinal cord of Lewis rats during the attack and recovery of experimental autoimmune encephalomyelitis Brain Res. 491 1989 374 378 (Pubitemid 19163389)
23. M. Lee, C. Schwab, and P.L. McGeer Astrocytes are GABAergic cells that modulate microglial activity Glia 59 2011 152 165
24. M. Levite Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors Cur. Opin. Pharmacol. 8 2008 460 471
25. A. MacKenzie-Graham, M.R. Tinsley, and K.P. Shah Cerebellar cortical atrophy in experimental autoimmune encephalomyelitis Neuroimage 32 2006 1016 1023 (Pubitemid 44278686)
26. A. MacKenzie-Graham, S.K. Tiwari-Woodruff, and G. Sharma Purkinje cell loss in experimental autoimmune encephalomyelitis Neuroimage 48 2009 637 651
27. M. Markianos, G. Koutsis, M.E. Evangelopoulos, D. Mandellos, G. Karahalios, and C. Sfagos Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis J. Neurochem. 108 2009 158 164
28. Y. Matsumoto, H. Sakuma, K. Kohyama, and I.K. Park Paralysis of CD4(+)CD25(+) regulatory T cell response in chronic autoimmune encephalomyelitis J. Neuroimmunol. 187 2007 44 54 (Pubitemid 47001536)
29. K. Mitosek-Szewczyk, G. Sulkowski, Z. Stelmasiak, and L. Struzynska Expression of glutamate transporters GLT-1 and GLAST in different regions of rat brain during the course of experimental autoimmune encephalomyelitis Neuroscience 155 2008 45 52
30. M. Ohgoh, T. Hanada, T. Smith, T. Hashimoto, M. Ueno, Y. Yamanishi, M. Watanabe, and Y. Nishizawa Altered expression of glutamate transporters in experimental autoimmune encephalomyelitis J. Neuroimmunol. 125 2002 170 178 (Pubitemid 34327467)
31. C.J. Olechowski, J.J. Truong, and B.J. Kerr Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE) Pain 141 2009 156 164
32. M. Onuki, M.M. Ayers, C.C. Bernard, and J.M. Orian Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice Microsc. Res. Tech. 52 2001 731 739 (Pubitemid 32222200)
33. M. Parent, D. Bush, G. Rauw, S. Master, F. Vaccarino, and G. Baker Analysis of amino acids and catecholamines, 5-hydroxytryptamine and their metabolites in brain areas in the rat using in vivo microdialysis Methods 23 2001 11 20 (Pubitemid 32846013)
34. A.C. Paula-Lima, F.G. De Felice, J. Brito-Moreira, and S.T. Ferreira Activation of GABA(A) receptors by taurine and muscimol blocks the neurotoxicity of beta-amyloid in rat hippocampal and cortical neurons Neuropharmacology 49 2005 1140 1148 (Pubitemid 41608638)
35. A. Petrescu, E. Constantinescu, N. Anghelescu, and C. Balaita Experimental allergic encephalomyelitis III. A morpho-biochemical study correlating amino acid concentrations in the nervous tissue with histopathologic changes Neurol. Psychiatr. (Bucur) 14 1976 211 223 (Pubitemid 8027377)
36. D. Pitt, P. Werner, and C.S. Raine Glutamate excitotoxicity in a model of multiple sclerosis Nat. Med. 6 2000 67 70 (Pubitemid 30048528)
37. C.Y. Saab, M.J. Craner, Y. Kataoka, and S.G. Waxman Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis Exp. Brain Res. 158 2004 1 8 (Pubitemid 39208518)
38. P. Saransaari, and S.S. Oja Excitatory amino acids evoke taurine release from cerebral cortex slices from adult and developing mice Neuroscience 45 1991 451 459
39. P. Sarchielli, L. Greco, A. Floridi, and V. Gallai Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid Arch. Neurol. 60 2003 1082 1088 (Pubitemid 36975795)
40. J. Sasabe, T. Chiba, M. Yamada, K. Okamoto, I. Nishimoto, M. Matsuoka, and S. Aiso d-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis EMBO J. 26 2007 4149 4159 (Pubitemid 47462099)
41. L. Steinman, and S.S. Zamvil How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis Ann. Neurol. 60 2006 12 21
42. J.F. Stover, U.E. Pleines, M.C. Morganti-Kossmann, T. Kossmann, K. Lowitzsch, and O.S. Kempski Neurotransmitters in cerebrospinal fluid reflect pathological activity Eur. J. Clin. Invest. 27 1997 1038 1043 (Pubitemid 28012626)
43. M. Sun, and C. Xu Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia Cell Mol. Neurobiol. 28 2008 593 611 (Pubitemid 351624504)
44. L. Turecky, B. Liska, and I. Pechan Glycine in the central nervous system in experimental allergic encephalomyelitis J. Neurochem. 35 1980 735 738 (Pubitemid 10046906)
45. J. van Beek, M. van Meurs, and B.A. t Hart Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation J. Immunol. 174 2005 2353 2365 (Pubitemid 40223985)
46. P. Vollmar, S. Nessler, S.R. Kalluri, H.P. Hartung, and B. Hemmer The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines Int. J. Neuropsychopharmacol. 12 2009 525 536
47. C. Wegner, and C. Stadelmann Gray matter pathology and multiple sclerosis Curr. Neurol. Neurosci. Rep. 9 2009 399 404
48. P. Werner, D. Pitt, and C.S. Raine Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage Ann. Neurol. 50 2001 169 180 (Pubitemid 32738141)
49. S.R. White, G.K. Samathanam, R.M. Bowker, and M.W. Wessendorf Damage to bulbospinal serotonin-, tyrosine hydroxylase-, and TRH-containing axons occurs early in the development of experimental allergic encephalomyelitis in rats J. Neurosci. Res. 27 1990 89 98 (Pubitemid 20321756)
50. J.R. Wujek, C. Bjartmar, E. Richer, R.M. Ransohoff, M. Yu, V.K. Tuohy, and B.D. Trapp Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis J. Neuropathol. Exp. Neurol. 61 2002 23 32 (Pubitemid 34027718)
51. G.X. Zhang, S. Yu, B. Gran, J. Li, D. Calida, E. Ventura, X. Chen, and A. Rostami T cell and antibody responses in remitting-relapsing experimental autoimmune encephalomyelitis in (C57BL/6 x SJL) F1 mice J. Neuroimmunol. 148 2004 1 10 (Pubitemid 38229553)
52. B. Zhu, L. Luo, G.R. Moore, D.W. Paty, and M.S. Cynader Dendritic and synaptic pathology in experimental autoimmune encephalomyelitis Am. J. Pathol. 162 2003 1639 1650 (Pubitemid 36512847)